Drugs A - Z

It is used to promote and maintain weight loss in obese patients

Generic Name: sibutramine

There is an FDA Alert for this drug. Click here to view it.

Special Alerts:

On October 8, 2010, the manufacturer announced a voluntary withdrawal of sibutramine from the US market. The withdrawal was requested by FDA following review of new data on cardiovascular risk. (See Cardiovascular Effects under Cautions.)


FDA approved a REMS for sibutramine to ensure that the benefits of a drug outweigh the risks. The REMS may apply to one or more preparations of sibutramine and consists of the following: medication guide. See the FDA REMS page ([Web]) or the ASHP REMS Resource Center ([Web]).

The Healthline Site, its content, such as text, graphics, images, search results, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.


Sibutramine Resources